Tags

Type your tag names separated by a space and hit enter

The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961.
Wien Klin Wochenschr. 2001 Nov 15; 113(22):851-4.WK

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Biography
Classical Article
Historical Article
Journal Article

Language

eng ger

PubMed ID

11763859

Citation

Birkmayer, W, and O Hornykiewicz. "The Effect of L-3,4-dihydroxyphenylalanine (= DOPA) On Akinesia in Parkinsonism. 1961." Wiener Klinische Wochenschrift, vol. 113, no. 22, 2001, pp. 851-4.
Birkmayer W, Hornykiewicz O. The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961. Wien Klin Wochenschr. 2001;113(22):851-4.
Birkmayer, W., & Hornykiewicz, O. (2001). The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961. Wiener Klinische Wochenschrift, 113(22), 851-4.
Birkmayer W, Hornykiewicz O. The Effect of L-3,4-dihydroxyphenylalanine (= DOPA) On Akinesia in Parkinsonism. 1961. Wien Klin Wochenschr. 2001 Nov 15;113(22):851-4. PubMed PMID: 11763859.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961. AU - Birkmayer,W, AU - Hornykiewicz,O, PY - 2002/1/5/pubmed PY - 2002/1/17/medline PY - 2002/1/5/entrez SP - 851 EP - 4 JF - Wiener klinische Wochenschrift JO - Wien Klin Wochenschr VL - 113 IS - 22 SN - 0043-5325 UR - https://www.unboundmedicine.com/medline/citation/11763859/The_effect_of_l_34_dihydroxyphenylalanine__=_DOPA__on_akinesia_in_parkinsonism__1961_ L2 - https://medlineplus.gov/parkinsonsdisease.html DB - PRIME DP - Unbound Medicine ER -